Ocular Therapeutix OCUL Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's stock issuance proceeds?
- Ocular Therapeutix (OCUL) reported stock issuance proceeds of $294K in Q1 2026.
- How has Ocular Therapeutix's stock issuance proceeds changed year-over-year?
- Ocular Therapeutix's stock issuance proceeds decreased by 93.0% year-over-year, from $4.18M to $294K.
- What is the long-term trend for Ocular Therapeutix's stock issuance proceeds?
- Over 2 years (2022 to 2025), Ocular Therapeutix's stock issuance proceeds has grown at a 532.2% compound annual growth rate (CAGR), from $514K to $20.54M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.